ABSTRACT
The term "mobbing" has today erroneously come to be a huge general recepticle for all the conflicts and interpersonal problems breaking out in the work environment. The author, who collaborates as clinical psychologist in an anti-mobbing network, shows that frequently events at work and personality structures are closely connected. In particular, attention to the modes of coping becomes a fundamental aspect for the diagnosis of mobbing. If psychic distress has gradually moved from a neurotic basis to a more preponderantly narcissistic pathology, the author underlines that precisely narcissistic pathologies may be correlated to the vast container of mobbing.
Subject(s)
Adaptation, Psychological , Occupational Health , Social Behavior , Adult , Female , Humans , Male , NarcissismABSTRACT
After a description of the pharmacological and therapeutic properties of Nomifensine, the results obtained by administering the drug to 40 elderly patients suffering from depression are reported. A double blind test with a placebo was conducted in two separate stages. Dosage was 70-75 mg per diem. Effects were evaluated on a slightly modified Plutchik scale. The drug alleviated depressive symptoms to a statistically significant greater degree than the placebo. Subjective side effects were minimal. No A.P. or biohumoral changes were observed.
Subject(s)
Depression/drug therapy , Isoquinolines/therapeutic use , Nomifensine/therapeutic use , Aged , Double-Blind Method , Female , Humans , Male , Middle AgedABSTRACT
A cross-over trial was run to compare the effects of two delayed-action nicotinic acid polyesters (pentaerythritol-tetranticotinate, PETN, and inositol-hexanicotinate, MIEN) in 59 aged normo- and dyslipaemic subjects. PETN tended to normalise the lipid picture in much the same way as nicotin acid, without a drastic effect on circulating lipids and lipoproteins. MIEN, on the other hand, had only a slight effect on total blood lipids, and appeared to be ineffective or negative with respect to the other lipid parameters. PETN proved capable of releasing active concentrations of nicotinic acid in vivo for a period of time that was sufficient to correct hyperlipaemia in age subjects. The side-effects were slight, infrequent and quickly reversible.
Subject(s)
Hyperlipidemias/drug therapy , Inositol/therapeutic use , Niceritrol/therapeutic use , Nicotinic Acids/therapeutic use , Age Factors , Aged , Cholesterol/blood , Clinical Trials as Topic , Delayed-Action Preparations , Drug Evaluation , Female , Humans , Inositol/adverse effects , Lipoproteins/blood , Liver/drug effects , Male , Middle Aged , Niceritrol/adverse effects , Nicotinic Acids/adverse effects , Phospholipids/blood , Triglycerides/bloodABSTRACT
The antiarthrosic effectiveness with respect to spontaneous pain upon movement and pressure, of alclofenac (4-allyloxy-3-chlorophenyl-acetic acid) was tested in a homogeneous group of elderly patients and compared with orally administered indomethacin. The research was carried out in strictly controlled, double-blind experimental conditions. The results obtained suggest that 500 mg of the new anti-inflammatory analgesic have the same action as 25 mg of indomethacin but with a lower incidence of the side effects common to all anti-inflammatory substances. Thanks to its good tolerability and high effectiveness, the new drug should be of considerable utility in the treatment of arthrosis in the elderly and in painful, inflammatory complications.